Intracellular TDP-43 amyloid nucleates from arrested nascent condensates
Jianzheng WuiD, Shriram VenkatesaniD, Jacob Jensen, Tayla MilleriD, Jeffrey J. LangeiD, Sean McKinneyiD, Einar Halldorsson, Zulin YuiD, Vignesh M. P. BabuiD, Laura Sancho Salazar, Jeff HaugiD, Jay R. UnruhiD, Randal HalfmanniD
Abstract
TDP-43 is a model protein for pathophysiological phase transitions, forming a multitude of intracellular assemblies with different physical properties. Physiological condensation is widely presumed to precede pathological aggregation, but the causal relationships between different modes of assembly in vivo are still unclear. Here we use Distributed Amphifluoric FRET (DAmFRET) and complementary approaches to map the phase space of TDP-43 self-assembly in yeast cells. We discovered that the low-complexity C-terminal domain (CTD) on its own partitions into soluble clusters that dynamically arrest en route to liquid-liquid phase separation. These clusters uniquely supported amyloid formation, and only when templated by pre-existing amyloids of other proteins. Self-interacting modules outside the CTD, whether in the full-length TDP-43, pathological C-terminal fragments, or fusion partners, all suppressed amyloid nucleation. They did this by promoting CTD condensation beyond the arrested state. Stress and cotranslational self-association had the same effect. We leveraged this property of condensation to stop CTD amyloid formation by co-expressing an oligomeric binder in cells. Our findings reveal that TDP-43 amyloid formation occurs only under very specific physical and biological circumstances that present new opportunities for therapeutic control.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An autoinhibitory regulatory switch governs heterotypic phase separation and liquid-to-solid phase transition of TDP-43 and tau into cytotoxic amyloids
Anuja Walimbe, Snehasis Sarkar, … Samrat Mukhopadhyay·bioRxiv·May 27, 2026
- Phe-Gly Motifs Drive Fibrillization of TDP-43's Prion-Like Domain Droplets
D. Pantoja-Uceda, C. Stuani, … M. Mompean·bioRxiv·Feb 20, 2020
- TDP-43 oligomers detected as initial intermediate species during aggregate formation
Rachel L. French, Ashley N. Reeb, … Yuna M. Ayala·bioRxiv·Dec 17, 2018
- Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation
L. A. Gruijs da Silva, F. Simonetti, … D. Dormann·The EMBO JournalPeer-reviewed·Feb 3, 2022
- TDP-43 amyloid conversion in cells tracks the net charge of a polyampholyte motif, not condensate solidification
Yoonjeong Choi, Yemuk Kang, … Kiwon Song·bioRxiv·Oct 16, 2026
- Multi-Domain Interplay Controls Full-Length TDP-43 Phase Separation and Condensate Dynamics
Xiaofei Ping, Rodrique G. M. Badr, … Lukas S. Stelzl·bioRxiv·Oct 7, 2026